(GLMD) Galmed Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Galmed Pharmaceuticals | (GLMD) share price targets
Complete technical analysis of Galmed Pharmaceuticals (GLMD) by charts plus indicators, forecast predictions and share price targets for Galmed Pharmaceuticals (GLMD)
Galmed Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-08-12 View latest technical analysis
10 day averaged volume of Galmed Pharmaceuticals is 197600
Date | Daily Closing Price | Open | High | Low | Volume |
12 Tue Aug 2025 | 1.42 | 1.48 | 1.54 | 1.42 | 0.424 times |
11 Mon Aug 2025 | 1.45 | 1.44 | 1.48 | 1.40 | 0.352 times |
08 Fri Aug 2025 | 1.45 | 1.36 | 1.48 | 1.32 | 1.011 times |
07 Thu Aug 2025 | 1.37 | 1.42 | 1.44 | 1.36 | 0.666 times |
06 Wed Aug 2025 | 1.45 | 1.58 | 1.58 | 1.43 | 1.406 times |
05 Tue Aug 2025 | 1.60 | 1.61 | 1.70 | 1.57 | 0.518 times |
01 Fri Aug 2025 | 1.55 | 1.61 | 1.61 | 1.48 | 1.208 times |
31 Thu Jul 2025 | 1.63 | 1.74 | 1.75 | 1.62 | 0.996 times |
30 Wed Jul 2025 | 1.69 | 1.78 | 1.80 | 1.68 | 1.424 times |
29 Tue Jul 2025 | 1.79 | 1.93 | 1.93 | 1.78 | 1.33 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 1.5, but if it comes above 1.5, then a intra day buy could be more profitable.
If you take a sell trade below 1.5, then use 1.5 as stoploss and 1.2 as target. However if you take a buy trade in stock , then use 1.5 as stoploss and 1.76 as target.
Share price targets for Galmed Pharmaceuticals (GLMD)
Target Type | Value |
Downside Target | 1.15 |
Downside Target | 1.21 |
Downside Target | 1.32 |
Downside Target | 1.40 |
Upside Target | 1.48 |
Upside Target | 1.54 |
Upside Target | 1.61 |
Upside Target | 1.69 |
Upside Target | 1.77 |
Upside Target | 1.94 |
Upside Target | 2.03 |
Upside Target | 2.09 |
Upside Target | 2.34 |
Upside Target | 2.68 |
Intraday share price targets for Galmed Pharmaceuticals (GLMD)
Target Type | Value |
Downside Intraday Target | 1.37 |
Downside Intraday Target | 1.31 |
Upside Intraday Target | 1.51 |
Upside Intraday Target | 1.59 |
Upside Intraday Target | 1.45 |
Weekly technical analysis of Galmed Pharmaceuticals (GLMD)
Date | Weekly Closing Price | Open | High | Low | Volume |
12 Tue Aug 2025 | 1.42 | 1.44 | 1.54 | 1.40 | 0.215 times |
08 Fri Aug 2025 | 1.45 | 1.61 | 1.70 | 1.32 | 0.596 times |
01 Fri Aug 2025 | 1.55 | 2.02 | 2.03 | 1.48 | 0.581 times |
25 Fri Jul 2025 | 1.99 | 1.98 | 2.09 | 1.61 | 0.901 times |
18 Fri Jul 2025 | 1.83 | 1.94 | 2.34 | 1.77 | 0.973 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Galmed Pharmaceuticals (GLMD)
Date | Monthly Closing Price | Open | High | Low | Volume |
12 Tue Aug 2025 | 1.42 | 1.61 | 1.70 | 1.32 | 0.136 times |
31 Thu Jul 2025 | 1.63 | 1.83 | 2.34 | 1.61 | 1.253 times |
30 Mon Jun 2025 | 1.84 | 1.49 | 1.94 | 1.42 | 0.185 times |
30 Fri May 2025 | 1.43 | 1.34 | 1.69 | 1.15 | 0.547 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Galmed Pharmaceuticals (GLMD)
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Galmed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Galmed Pharmaceuticals in short term and the sell signal is strong.
Galmed Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Galmed Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Galmed Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.57 and Galmed Pharmaceuticals (GLMD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Galmed Pharmaceuticals (GLMD) stock. Volume based technical analysis of Galmed Pharmaceuticals (GLMD) stock is negative.
Galmed Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Galmed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Galmed Pharmaceuticals in short term and the sell signal is strong.
Galmed Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Galmed Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Galmed Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.57 and Galmed Pharmaceuticals (GLMD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Galmed Pharmaceuticals (GLMD) stock. Volume based technical analysis of Galmed Pharmaceuticals (GLMD) stock is negative.
Galmed Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.